2022 annual financial data
CytoMed Therapeutics 2022 Net margin
Direct answer
Net margin was -835.73%.
Operating income was -2,283,246 SGD and net income was -3,055,471 SGD.
Operating cash flow was -1,404,918 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 365,604 SGD
- Operating income
- -2,283,246 SGD
- Net income
- -3,055,471 SGD
- Operating cash flow
- -1,404,918 SGD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all CytoMed Therapeutics financial years